Best strategy if IMU's management want to take the product to Ph3 is for the board to unanimously reject the offer and then do a CR with no discount near the T/O price to fund the Ph3 clinical trial and then wait for BP to offer a license deal near the end of Ph3.
Best strategy if IMU's management want to take the product to...
-
- There are more pages in this discussion • 2,367 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
-0.002(3.51%) |
Mkt cap ! $404.2M | |||
| Open | High | Low | Value | Volume |
| 5.7¢ | 5.9¢ | 5.5¢ | $1.012M | 18.02M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 590122 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 1408449 | 3 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |